In 2022, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.
Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspectives and insightful views as authors.
Outstanding Authors (2022)
Takaaki Oba is an assistant professor of Division of Breast and Endocrine Surgery, Department of Surgery at Shinshu University School of Medicine, Japan. His research area includes thyroid cancer, breast cancer, parathyroid disease. His research focuses are developing novel in situ immunotherapy for breast and thyroid cancer and identifying blood-based prognostic biomarkers for breast and thyroid cancer. Breast and thyroid cancer are malignancies which are accessible for intratumoral injections, which can be an advantage to develop in situ immunotherapy. He has already introduced novel in situ immunotherapy in a study (Oba et al. Nat Commun;11:5415, 2020, Oba et al. J Immunother Cancer;9: e002432, 2021, Oba et al. Cancer Res;81:6183-6195,2022). He aims to develop more in situ immunotherapy for breast and thyroid cancer. Dr. Oba’s personal page could be find here.
For Dr. Oba, there are two possible reasons why academic writing is important. One is that academic writing enables the gathering of knowledge. Clinicians have an obligation to choose the best treatment for the patient by referring to guidelines and other information that have been established through the convergence of knowledge. However, in a rare condition such as hyperparathyroidism in children with hypercalcemic crisis as presented in this paper, it is not possible to design a randomized clinical trial. A reference for the treatment of such conditions would be a published case report. The second is for self-improvement. In academic writing, clinicians can acquire in-depth knowledge that cannot be obtained by simply doing clinical work.
In Dr. Oba’s opinion, the requirements for a good academic paper are that the objectives of the research are clear, that an appropriate approach to those objectives is planned, and that the results are clear and universal. Furthermore, the results should contribute to the future progress of medicine.
Science advances rapidly day by day. To ensure scientific writing is up-to-date and can give new insights to the field of research, Dr. Oba thinks that individual efforts to update information are necessary. However, there is not so much that one can do on one’s own. Therefore, regular meetings are held so that researchers can share new data updates of their team.
Speaking of applying for institutional review board (IRB) approval, Dr. Oba points out that approval by Ethics Committee is mandatory. It is especially important that the research plan be reviewed by an external reviewer to ensure that it is properly designed. Without this, there is a risk that improperly and unethically designed research will be conducted.
(By Nicole J. Li, Brad Li)